Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sustained-release dexamphetamine feasibility study for crack-cocaine dependence in heroin-assisted treatment
NL-OMON39005Phase 2Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cocaine use disorder (CUD) comparing Dexamphetamine SR + heroin-assisted treatment with Placebo + heroin-assisted treatment (2 arms). Primary endpoint: Total number of days of crack-cocaine use during 12 weeks. Started Aug 2014; status: active, not recruiting.
02
Drugs
dextroamphetamine
03
Conditions
cocaine use disorder (CUD)
Beyond the preview
Go deeper on NL-OMON39005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39005.